The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
A. Huijbers(Leiden University Medical Center), Wilma E. Mesker(Leiden University Medical Center), David Kerr(University of Oxford), Susan Dutton(Oxford Centre for Diabetes, Endocrinology and Metabolism), Elaine Johnstone(University of Oxford), Enric Domingo(Universitätsklinikum Erlangen), Vincent T.H.B.M. Smit(Leiden University Medical Center), Rachel Midgley(University of Oxford), Christopher C. McConkey(University of Warwick), Eliane C.M. Zeestraten, Gabi W. van Pelt, B F Warren(John Radcliffe Hospital), Rob A.�E.�M. Tollenaar(Leiden University Medical Center)
Cited by 348
Related Papers
International network of cancer genome projects
|Nature|2010|2.4k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains
|Nature Genetics|2011|695
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer
|British journal of surgery|2004|665
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
|Genome Research|2011|610